{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T16:33:54Z","timestamp":1766162034075,"version":"3.48.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,19]]},"DOI":"10.7759\/cureus.99634","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T16:30:12Z","timestamp":1766161812000},"source":"Crossref","is-referenced-by-count":0,"title":["Neuropsychiatric Systemic Lupus Erythematosus: A Case Series"],"prefix":"10.7759","author":[{"given":"Manuel A","family":"Garcia-Smester","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asha","family":"Patnaik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F","article-title":"The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes","volume":"42","year":"1999","unstructured":"The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 1999, 42.4599. 10.1002\/1529-0131(199904)42:4&lt;599::AID-ANR2&gt;3.0.CO;2-F","journal-title":"Arthritis Rheum"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-015-0269-8","article-title":"Neuropsychiatric lupus: a mosaic of clinical presentations","volume":"13","author":"Kivity S","year":"2015","unstructured":"Kivity S, Agmon-Levin N, Zandman-Goddard G, Chapman J, Shoenfeld Y. Neuropsychiatric lupus: a mosaic of clinical presentations. BMC Med. 2015, 13:43. 10.1186\/s12916-015-0269-8","journal-title":"BMC Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2018.1492309","article-title":"Diagnostic approach to neuropsychiatric lupus erythematosus: what should we do?","volume":"130","author":"Zardi EM","year":"2018","unstructured":"Zardi EM, Giorgi C, Zardi DM. Diagnostic approach to neuropsychiatric lupus erythematosus: what should we do?. Postgrad Med. 2018, 130:536-47. 10.1080\/00325481.2018.1492309","journal-title":"Postgrad Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)92292-n","article-title":"Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis","volume":"340","author":"Boumpas DT","year":"1992","unstructured":"Boumpas DT, Austin HA 3rd, Vaughn EM, Klippel JH, Steinberg AD, Yarboro CH, Balow JE. Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet. 1992, 340:741-5. 10.1016\/0140-6736(92)92292-n","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa404","article-title":"The management of neuropsychiatric lupus in the 21st century: still so many unmet needs?","volume":"59","author":"Govoni M","year":"2020","unstructured":"Govoni M, Hanly JG. The management of neuropsychiatric lupus in the 21st century: still so many unmet needs?. Rheumatology (Oxford). 2020, 59:v52-62. 10.1093\/rheumatology\/keaa404","journal-title":"Rheumatology (Oxford)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.106351","article-title":"Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus","volume":"69","author":"Hanly JG","year":"2010","unstructured":"Hanly JG, Urowitz MB, Su L, et al.. Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus. Ann Rheum Dis. 2010, 69:529-35. 10.1136\/ard.2008.106351","journal-title":"Ann Rheum Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.56.7.481","article-title":"Pathogenesis of systemic lupus erythematosus","volume":"56","author":"Mok CC","year":"2003","unstructured":"Mok CC, Lau CS. Pathogenesis of systemic lupus erythematosus. J Clin Pathol. 2003, 56:481-90. 10.1136\/jcp.56.7.481","journal-title":"J Clin Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11174955","article-title":"Progress in the pathogenesis and treatment of neuropsychiatric systemic lupus erythematosus","volume":"11","author":"Wang M","year":"2022","unstructured":"Wang M, Wang Z, Zhang S, et al.. Progress in the pathogenesis and treatment of neuropsychiatric systemic lupus erythematosus. J Clin Med. 2022, 11:10.3390\/jcm11174955","journal-title":"J Clin Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/nri2529","article-title":"Losing your nerves? Maybe it's the antibodies","volume":"9","author":"Diamond B","year":"2009","unstructured":"Diamond B, Huerta PT, Mina-Osorio P, Kowal C, Volpe BT. Losing your nerves? Maybe it's the antibodies. Nat Rev Immunol. 2009, 9:449-56. 10.1038\/nri2529","journal-title":"Nat Rev Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/art.30157","article-title":"Neuropsychiatric systemic lupus erythematosus: lessons learned from magnetic resonance imaging","volume":"63","author":"Luyendijk J","year":"2011","unstructured":"Luyendijk J, Steens SC, Ouwendijk WJ, et al.. Neuropsychiatric systemic lupus erythematosus: lessons learned from magnetic resonance imaging. Arthritis Rheum. 2011, 63:722-32. 10.1002\/art.30157","journal-title":"Arthritis Rheum"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.130476","article-title":"EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs","volume":"69","author":"Bertsias GK","year":"2010","unstructured":"Bertsias GK, Ioannidis JP, Aringer M, et al.. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis. 2010, 69:2074-82. 10.1136\/ard.2010.130476","journal-title":"Ann Rheum Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.61678","article-title":"Neuropsychiatric systemic lupus erythematosus: a systematic review","volume":"16","author":"Rice-Canetto TE","year":"2024","unstructured":"Rice-Canetto TE, Joshi SJ, Kyan KA, Siddiqi J. Neuropsychiatric systemic lupus erythematosus: a systematic review. Cureus. 2024, 16:e61678. 10.7759\/cureus.61678","journal-title":"Cureus"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/0961203313509295","article-title":"Rituximab in systemic lupus erythematosus: an updated systematic review and meta-analysis","volume":"22","author":"Duxbury B","year":"2013","unstructured":"Duxbury B, Combescure C, Chizzolini C. Rituximab in systemic lupus erythematosus: an updated systematic review and meta-analysis. Lupus. 2013, 22:1489-503. 10.1177\/0961203313509295","journal-title":"Lupus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/389787-neuropsychiatric-systemic-lupus-erythematosus-a-case-series","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T16:30:13Z","timestamp":1766161813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/389787-neuropsychiatric-systemic-lupus-erythematosus-a-case-series"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.99634","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,19]]}}}